University of Edinburgh EASTBIO CASE PhD: Imaging Protein-Therapeutic Trafficking with Fluorescent Non-Canonical Amino Acids

University of Edinburgh EASTBIO CASE PhD: Imaging Protein-Therapeutic Trafficking with Fluorescent Non-Canonical Amino Acids

Research Question and Fit

This Edinburgh EASTBIO CASE project asks what fluorescence can reliably reveal about a protein therapeutic's journey inside a cell: where it goes, how long it stays, and whether it is recycled or degraded. It combines compact chemical reporters with fluorescence lifetime imaging microscopy (FLIM), academic chemical-biology expertise and Externa Biosciences collaboration. The scientific opportunity is to relate an optical signal to protein fate without mistaking the reporter's behaviour for the process being measured. Four-year competitive funding includes maintenance and an explicit Edinburgh contribution covering international tuition above the Home rate.

The deadline is 16 November 2026, without a stated clock or time zone. Send the EASTBIO form and PDF transcripts to IRRSchoolPGR@ed.ac.uk, with template references sent to the same address by the deadline. The main scientific question is whether a reporter's optical response can reliably distinguish trafficking events without changing the protein being measured. Formal registration, industrial supervision and individual 2027 funding terms remain to be confirmed.

Research Problem and Doctoral Work

A protein reaching an endosome or lysosome has not necessarily completed the biological event of interest. Entry, sorting, recycling and degradation occur on different trajectories. A bright spot may show local probe accumulation without establishing residence time, protein integrity or release. The project therefore links reporter chemistry to quantitative cell-biological interpretation.

The three advertised aims address different parts of that measurement problem:

• Develop and characterise pH-responsive fluorescent non-canonical amino acids.
• Introduce site-specific labels into protein and peptide scaffolds; nanobodies and antibodies are examples, not already validated universal formats.
• Use live-cell FLIM to quantify internalisation, endosomal sorting, recycling and lysosomal degradation.

Genetic code expansion, molecular characterisation, imaging and quantitative analysis are training categories. Synthesis, protein studies and display-library methods also appear in the training offer; they are not a requirement to arrive proficient in every technique.

Fluorescence lifetime is largely, rather than absolutely, independent of concentration and expression level. It adds information beyond intensity, but a useful measurement still requires adequate signal, an appropriate model for mixed lifetimes, and evidence connecting optical changes to the cellular environment. Environment sensitivity is itself the intended response, so a lifetime change cannot automatically identify a unique compartment or causal mechanism. Reporter-induced changes in protein binding or trafficking, background fluorescence and heterogeneity can affect interpretation.

Plausible doctoral outputs include a bounded characterisation of reporter behaviour, a reproducible image-analysis strategy, and evidence separating localisation from downstream protein fate in selected models. These are potential contributions, not promised clinical efficacy or a validated universal platform. The announcement mentions earlier lifetime-based ADC probes; the identified 2025 ADC paper instead describes fluorogenic intensity switches. It supports trafficking and release-measurement expertise but does not independently verify that specific lifetime-based claim. Asking which earlier reference the team intends is worthwhile.

The frontier here is making chemical reporters informative without making them biologically misleading. More labels or more imaging channels do not by themselves resolve the inverse problem of inferring protein fate from fluorescence. An informative PhD would define which observations support a trafficking interpretation and which remain ambiguous.

School, Programme and Field Context

The University of Edinburgh awards the degree. The advertised host is the School of Regeneration and Repair in the College of Medicine and Veterinary Medicine, with School of Chemistry involvement. IRR and its Centre for Inflammation Research provide the biomedical setting; Externa is an industrial collaborator, not a degree-awarding institution. EaStCHEM's Edinburgh–St Andrews partnership likewise does not establish a joint degree for this project.

The current 2027 Inflammation PhD page, course identifier 215, is relevant because it sits in the same School, names CIR/IRR and uses the same PGR administration address. It describes an ordinary three-year full-time PhD. It has not been confirmed as this studentship's registered programme or code, and its ordinary duration must not replace the advertised four-year EASTBIO framework. Confirm whether registration uses this course or another four-year arrangement.

The course describes seminars, journal clubs, presentation events, supervisory training and specialist facility support in imaging, flow cytometry, bioinformatics and related areas. These are institutional resources, not guaranteed personal instrument time or unrestricted access. EASTBIO's framework for cohorts from 2025 concentrates core training in years one and two, with research emphasised in years three and four. Its current calendar is not the incoming student's personal timetable. CASE involvement supports industrial exposure; the actual placement duration, location and support are not specified here.

For institutional context, Edinburgh is 35th overall in QS 2027 and fourth in UK research power in REF 2021, as reported by the university. A more relevant chemistry signal is the joint EaStCHEM REF 2021 submission: 100% world-leading research environment, over 99% of outputs world-leading or internationally excellent. These joint subject results are not an IRR-only ranking, a score for this supervisory team or a guarantee of training quality.

Supervisor and Lab Assessment

Professor Marc Vendrell holds the Chair of Translational Chemistry and Biomedical Imaging and leads chemical-imaging work within IRR; his public contact is Marc.Vendrell@ed.ac.uk. Dr Ewen Calder, ewen.calder@ed.ac.uk, is a Chancellor's Fellow in Health and Life spanning Chemistry and IRR, with peptide chemical-tool and display-method experience. Dr Ferran Nadal-Bufi is currently listed by the university as a Postdoctoral Research Fellow in Regeneration and Repair/CIR. All three are named in the project, but formal supervision shares and the named industrial mentor are not established.

Externa's own public site describes a genetic-code-expansion focus, a Cambridge, Massachusetts location and “In Stealth” status. It does not identify its staff or a student-placement agreement. The evidence does not establish that Nadal-Bufi is an Externa employee. Company guidance, day-to-day academic mentoring and industrial supervision should be separately clarified.

Three genuine recent originals coauthored by named supervisors show relevant capabilities:

Localisation versus release: JACS, 2025

Nadal-Bufi et al., DOI 10.1021/jacs.4c16842; Vendrell coauthor. The work distinguishes subcellular localisation from a subsequent release-related signal in tested ADC models. It demonstrates why lysosomal arrival alone is insufficient evidence of release. The available evidence includes the complete institutional abstract and indexed introduction, results and conclusions excerpts. The identified platform uses pH/enzyme-responsive fluorogenic switches; it is not independent proof of the announcement's lifetime-based ADC wording. Tested functional comparisons do not establish universal non-perturbation or clinical efficacy. Full methods, supplements and raw data are outside the available evidence.

Compact labels and lifetime-informed localisation

Nadal-Bufi et al., ACS Central Science 11:66–75, 2025 issue / 26 November 2024 online, DOI 10.1021/acscentsci.4c01249; Vendrell co-corresponding author. Available evidence includes the complete institutional abstract and original indexed introduction, selected results and conclusions. The study demonstrates compact labelling and lifetime-informed localisation in selected peptide/protein examples. It informs label-perturbation assessment and interpretation of cellular routing. It does not validate every antibody scaffold or provide a universal pH calibration. The online and issue dates describe one paper.

Multiplexed lifetime readouts in a different model

Suárez de Cepeda et al., Angewandte Chemie 2026, e21482, DOI 10.1002/anie.202521482; Nadal-Bufi and Vendrell coauthors. The complete institutional abstract and indexed conclusions describe a 36-nanoprobe collection and five-probe multiplexing within one spectral window. This is evidence of lifetime-readout expertise, but nanoprobes demonstrated in bacterial imaging are not genetically encoded amino acids validated in therapeutic antibodies or a mammalian trafficking platform. The available evidence is limited to the abstract and conclusions, not the complete methods, results or supplements.

The papers support a credible chemical-imaging environment with complementary expertise. They do not answer who will provide daily microscopy analysis, what training is available to a new student, or how instrument access and company-related data will be managed.

Funding, Application, and Living Cost

The specific announcement states four-year EASTBIO competition funding, maintenance and Home tuition, with Edinburgh covering the international fee difference for appointees. This is a positive full-tuition and maintenance route for eligible international applicants, including Chinese candidates. EASTBIO's international cap is 30% of annual intake, not an individual's admission probability or a basis for calculating this project's international places. A personal award is competitive; not yet holding one does not prevent beginning an application.

The £21,805 UKRI minimum is a 2026–27 reference, not a confirmed personal 2027 rate. Confirm the individual payment schedule, research support and any costs beyond the funded period. The relevant candidate course warns that additional research costs can depend on the project and funding scheme. Its generic range must not be assigned as a personal bill: determine what this studentship covers, including imaging, consumables and industrial travel. Research funding is not maintenance income.

For this competition, the stated route is email to IRRSchoolPGR@ed.ac.uk: completed EASTBIO form, PDF academic transcripts and references on the EASTBIO template by 16 November 2026. Complete the anonymous EDI survey and put its unique response identifier on the form. EASTBIO permits only one project application across the partnership; references may be academic or professional but cannot come from prospective project supervisors. Do not substitute Edinburgh Biology's EUCLID initial route, a midday cutoff or a two-week reference extension. The current IRR course itself says advertised funded projects follow their advert's procedure. Later formal registration may require certificates, translations, English evidence and other course documents.

The partnership's general selection framework points to a 1 October 2027 start; this project's exact start remains to be confirmed. A general directory opening date does not establish closure of this specific project; the saved advert likewise does not verify present availability.

Edinburgh's official single-postgraduate budget for 2026–27, calculated in March 2026, is £1,542 monthly / £18,504 for 52 weeks. Accommodation and utilities account for £978 per month. Subtracting that year's budget from that year's minimum UKRI stipend gives an illustrative £3,301, before excluded costs or individual spending differences. It is not guaranteed savings or a 2027 quote. The figure is for one person and cannot be assumed to support dependants.

EASTBIO excludes visa and IHS costs. The saved government references are £558 for a Student visa application and £776 per student visa year for IHS, with visa-length and part-year rules; these are not fixed 2027 charges. Flights, deposits and arrival cash also need budgeting. Whether CASE-related travel and accommodation are covered should be stated in the individual arrangement.

Applicant Fit and Preparation

The advert identifies chemistry, biochemistry and cell biology backgrounds as relevant. EASTBIO's academic baseline is a UK 2:1 or international equivalent; a Master's is not compulsory. Applicants below the undergraduate 2:1-equivalent threshold may still be considered if they have a Master's degree or significant relevant professional experience; this is individual assessment, not automatic eligibility. The advert's long method list describes training, not a requirement for mastery of every synthesis, display, protein and imaging technique before entry.

Chinese degrees have a positive route through Edinburgh's recognised-university or Priority List qualification guidance and EASTBIO's international eligibility. The country page's 80% / 80–85% table expressly covers taught programmes and two named MScR courses; it is not a confirmed percentage threshold for this PhD. Obtain a programme-specific equivalence assessment rather than assuming either a universal Master's requirement or a fixed Chinese score.

If the relevant 2027 Inflammation course is confirmed, its English requirements are IELTS 6.5 overall, 6.0 each; TOEFL before 21 January 2026: 92 overall, 23 each, and on or after that date 4.5 overall, 4.5 each. It excludes IELTS One Skill Retake and TOEFL MyBest. IELTS and TOEFL generally must be no more than two years old on the first day of the start month. An English-medium degree can qualify under approved-country/university rules; Chinese English-medium study is not automatically exempt. These are a relevant current course's conditions, not an already confirmed personal offer or imported Biology requirements.

Useful preparation is evidence of careful measurement, reproducible quantitative analysis and an ability to distinguish reporter behaviour from the biology being inferred. A discussion of signal interpretation, uncertainty and how to assess whether a label changes behaviour would be more informative than claiming expertise in every method. These are analyst suggestions, not additional mandatory documents.

Career and Transferable Skills

The skills connect to chemical biology, bioimaging, analytical research and biotechnology; professional career resources do not establish a job, salary or industrial placement offer. The industrial collaboration can broaden professional exposure, while the placement, publication and intellectual-property arrangements still need individual agreement. Career context

Next Actions and Questions to Verify

Before applying: confirm the email submission requirements and deadline clock/time zone with IRR administration. Ask which registered programme and four-year arrangement applies, how Chinese qualifications and English evidence will be assessed, and who is the industrial supervisor. Discuss the first research priorities without waiting for a personal funding award before applying.

At interview: ask which publication underlies the lifetime-based ADC statement; what supports connecting optical responses to compartments and protein fate; how label perturbation and mixed lifetimes will be handled; and what microscopy, analytical mentoring and company data access the student can actually use. Clarify academic versus industrial supervision and the feasible scope if a new reporter does not behave as expected.

Before accepting: verify full international tuition and maintenance coverage throughout the personal award, the 2027 stipend, research-cost provision, continuation charges, and industrial placement duration/location/expenses. Establish publication and intellectual-property arrangements, including any confidentiality restrictions. Confirm housing, arrival cash and CAS/visa conditions. ATAS depends on the actual registered research subject and offer; Chinese nationality is not an admission ban but is not exempt when a covered subject requires approval.

Evidence and Sources

The reference for the announcement’s lifetime-based ADC probes remains unresolved: the identified 2025 ADC study uses fluorogenic intensity switches. Saved materials do not verify current application availability; confirm with the School before applying.

School, team and original research

• Marc Vendrell current Chair and IRR chemical imaging group
• Ewen Calder current Chancellor Fellow and chemical biology interests
• Ferran Nadal Bufi current university role and original outputs
• Externa Biosciences official company page
• Current 2027 Inflammation PhD course at School Regeneration and Repair, candidate registration
• Nadal Bufi et al. 2025 fluorogenic ADC trafficking and release original
• Nadal Bufi et al. late stage minimal labeling cellular trafficking original, 2024 online / 2025 issue
• Suarez de Cepeda et al. 2026 TADF multiplexed FLIM original
• Vendrell laboratory current research interests
• Edinburgh QS 2027 overall ranking
• EaStCHEM joint Chemistry REF 2021 research environment and outputs

Funding, training, eligibility and costs

• EASTBIO current international fee-waiver and funding FAQ
• EastBio 2027 how to apply
• EastBio selection process
• EastBio training overview
• China postgraduate qualification equivalencies
• Edinburgh 2026/27 postgraduate living budget
• UKRI current stipend reference

Immigration and careers

• UK Student visa route and current fees
• UK student immigration healthcare charge
• ATAS nationality and covered subject rules
• Royal Society Biology careers resources